학술논문

Childhood attention‐deficit hyperactivity disorder: socioeconomic inequalities in symptoms, impact, diagnosis and medication.
Document Type
Article
Source
Child & Adolescent Mental Health. May2024, Vol. 29 Issue 2, p126-135. 10p.
Subject
*HEALTH services accessibility
*ATTENTION-deficit hyperactivity disorder
*RESEARCH funding
*MEDICAL prescriptions
*SOCIOECONOMIC factors
*DIAGNOSIS
*SYMPTOMS
*DESCRIPTIVE statistics
*LONGITUDINAL method
*QUALITY of life
*PSYCHOLOGY of mothers
*CONFIDENCE intervals
*EMPLOYMENT
*CHILDREN
Language
ISSN
1475-357X
Abstract
Background: Children from disadvantaged backgrounds are at greater risk of attention‐deficit hyperactivity disorder (ADHD)‐related symptoms, being diagnosed with ADHD, and being prescribed ADHD medications. We aimed to examine how inequalities manifest across the 'patient journey', from perceptions of impacts of ADHD symptoms on daily life, to the propensity to seek and receive a diagnosis and treatment. Methods: We investigated four 'stages': (1) symptoms, (2) caregiver perception of impact, (3) diagnosis and (4) medication, in two data sets: UK Millennium Cohort Study (MCS, analytic n ~ 9,000), with relevant (parent‐reported) information on all four stages (until 14 years); and a population‐wide 'administrative cohort', which includes symptoms (child health checks) and prescriptions (dispensing records), born in Scotland, 2010–2012 (analytic n ~ 100,000), until ~6 years. We described inequalities according to maternal occupational status, with percentages and relative indices of inequality (RII). Results: The prevalence of ADHD symptoms and medication receipt was considerably higher in the least compared to the most advantaged children in the administrative cohort (RIIs of 5.9 [5.5–6.4] and 8.1 [4.2–15.6]) and the MCS (3.08 [2.68–3.55], 3.75 [2.21–6.36]). MCS analyses highlighted complexities between these two stages, however, those from least advantaged backgrounds, with ADHD symptoms, were the least likely to perceive impacts on daily life (15.7% vs. average 19.5%) and to progress from diagnosis to medication (44.1% vs. average 72.5%). Conclusions: Despite large inequalities in ADHD symptoms and medication, parents from the least advantaged backgrounds were less likely to report impacts of ADHD symptoms on daily life, and their children were less likely to have received medication postdiagnosis, highlighting how patient journeys differed according to socioeconomic circumstances. [ABSTRACT FROM AUTHOR]